Recreating key features of the antibody factory in a dish
FDA Orphan Drug Designation and Rare Pediatric Disease Designation for sarcoma drug
Confidence boost for AI virtual cells for novel target discovery
Anti-fibrotic drug could be repurposed to control cell communication
IGI and AbbVie announce exclusive global licensing agreement for trispecific antibody
Angelman syndrome results published
Champions Oncology launches radiopharmaceutical services platform
Partnership created scale up cell-based mRNA design and manufacturing platform
New drug target for treating cancer and viral infections
Consortium looks to deliver fully automated robotics CGT manufacturing platform
WACKER Biotechnology Center opens in Munich
Emerging viral threats combatted by new dual lipid kinase inhibitor